131374-93-1 Usage
General Description
The chemical "2-(Aminomethyl)cyclobutyl]methanamine 2-hydroxypropanoic acid platinum salt" is a platinum-containing compound that consists of an aminomethylcyclobutyl methanamine molecule coordinated to a platinum atom, along with 2-hydroxypropanoic acid. The compound likely exhibits complex properties due to the presence of both the organic amine and carboxylic acid ligands, as well as the platinum metal center. It may have potential applications in catalysis, medicinal chemistry, or materials science, and further research into its properties and reactivity is necessary to fully understand its potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 131374-93-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,1,3,7 and 4 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 131374-93:
(8*1)+(7*3)+(6*1)+(5*3)+(4*7)+(3*4)+(2*9)+(1*3)=111
111 % 10 = 1
So 131374-93-1 is a valid CAS Registry Number.
InChI:InChI=1/C6H14N2.C3H6O3.Pt/c7-3-5-1-2-6(5)4-8;1-2(4)3(5)6;/h5-6H,1-4,7-8H2;2,4H,1H3,(H,5,6);
131374-93-1Relevant articles and documents
Anhydrous lobaplatin crystal, preparation method and pharmaceutical applications thereof
-
Paragraph 0298-0301, (2020/03/06)
The invention relates to an anhydrous lobaplatin crystal, a preparation method and pharmaceutical applications thereof, wherein the crystal form of lobaplatin is beta, the diffraction peaks exist at 2[theta] value of about 8.65, 17.34, 18.44, 19.53, 20.42, 21.02, 24.75, 25.47, 26.15, 27.82, 28.77, 30.30, 31.6594, 32.1970, 33.09, 35.10, 36.36, 38.45 and 39.51 in PXRD spectrum, and the error range of the 2[theta] value is 0.2. According to the invention, the preparation method comprises: adding lobaplatin trihydrate into DMSO, crystallizing for 15-20 h at 5-10 DEG C or -20 DEG C to-30 DEG C, precipitating the crystal, removing the solvent, and drying to obtain the crystal; and the prepared crystal is suitable for preparing various forms of pharmaceutical preparations and storing and using, and can be well used for treating cancers such as breast cancer, small cell lung cancer or chronic myelocytic leukemia.
